CANbridge CAN106 Phase 1 Data Presented at the European Hematology Association 2022 Congress

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

National University Hospital ,Singapore General ,Singapore ,Massachusetts ,United States ,Beijing ,China ,Austria ,Vienna ,Wien ,Greece ,Gerry Cox ,Geraldf Cox ,Chin Meng Khoo ,James Xue ,Qizhen Wu ,Chris Brinzey ,European Hematology Association Congress ,University Of Massachusetts Medical School Umass ,European Hematology Association ,Planet Communications ,Monoclonal Antibody In Clinical Development ,Development Strategist ,Canbridge Pharmaceuticals Inc ,Canbridge Pharmaceuticals ,Department Of Medicine ,Clinical Development ,International Conference On Complement Therapeutics ,Hematology Association Congress ,International Conference ,Complement Therapeutics ,Chief Development Strategist ,Interim Chief Medical Officer ,Ascending Dose Study ,Long Acting Anti C ,Monoclonal Antibody ,Charlene Song ,Medical Affairs ,Wuxi Biologics ,Massachusetts Medical School ,Pharmaceuticals Inc ,Investor Relations ,Business Wire ,Politics ,Health ,Business ,Congress ,